跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
MINT-DICLOFENAC
Authorized
STANDARD
MINT-DICLOFENAC
mint pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
7054f12f40b54f03
Company
mint pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
7054f12f40b54f03
Drug Approval Canada Name
MINT-DICLOFENAC
Product Name
MINT-DICLOFENAC
Status
Dormant
Status Date
2023-09-07
Original Market Date
2020-09-09
Din
02475197
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Ophthalmic
Schedule
Prescription
Ahfs
52:08.20
Atc Original
S01BC03 DICLOFENAC
Atc Name
s 01 bc 03
Aig Number
0114417004
Company Name
mint pharmaceuticals inc
Company Address
6575 Davand Drive, Mississauga, Ontario, Canada, L5T 2M3
Active Ingredients
DICLOFENAC SODIUM
0.1 % / W/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
7054f12f40b54f03
Type
Standard
Back to Health Canada Approvals
MINT-DICLOFENAC - Health Canada Drug Approval Details